Regeneron Pharmaceuticals
REGN
508 hedge funds and large institutions have $32.9B invested in Regeneron Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 186 increasing their positions, 198 reducing their positions, and 43 closing their positions.
14% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 43
11% more capital invested
Capital invested by funds: $29.5B → $32.9B (+$3.38B)
5% more funds holding in top 10
Funds holding in top 10: 19 → 20 (+1)
1% less funds holding
Funds holding: 511 → 508 (-3)
6% less repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 198
25% less call options, than puts
Call options by funds: $565M | Put options by funds: $757M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$602M |
| 2 |
JP Morgan Chase
New York
|
+$217M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$121M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$79.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$287M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$101M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$90.2M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$76.2M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$70.9M |
REGN Hedge Fund Activity: Q1 2015 in Review
508 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q1 2015, worth a combined $32.9B — up 11% from $29.5B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new REGN positions and 43 closed out — a net gain of 6 holders — while 186 added to existing stakes and 198 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $602M. The largest seller was Fidelity Investments, cutting an estimated $287M.
- 508 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q1 2015, down from 511 in Q4 2014.
- Funds reported $32.9B of Regeneron Pharmaceuticals stock for Q1 2015, up 11% quarter-over-quarter.
- 49 funds opened new Regeneron Pharmaceuticals positions in Q1 2015 and 43 closed out, a net change of +6 holders.
- The largest Regeneron Pharmaceuticals buyer in Q1 2015 was Janus Henderson Investors US, an estimated $602M added.
- The largest Regeneron Pharmaceuticals seller in Q1 2015 was Fidelity Investments, an estimated $287M sold.
Based on aggregated 13F filings for Q1 2015.